Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.

Cancer medicine - 1 Oct 2020

Saotome Keiko, Chiyoda Tatsuyuki, Aimono Eriko, Nakamura Kohei, Tanishima Shigeki, Nohara Sachio, Okada Chihiro, Hayashi Hideyuki, Kuroda Yuka, Nomura Hiroyuki, Susumu Nobuyuki, Iwata Takashi, Yamagami Wataru, Kataoka Fumio, Nishihara Hiroshi, Aoki Daisuke

Abstract excerpt

Precision medicine based on cancer genomics is being applied in clinical practice. However, patients do not always derive benefits from genomic testing. Here, we performed targeted amplicon exome sequencing-based panel tests, including 160 cancer-related genes (PleSSision-160), on 88 malignant ovarian tumors (high-grade serous carcinoma, 27; endometrioid carcinoma, 15; clear cell carcinoma, 30; mucinous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Testing

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32813918
DOI: 10.1002/cam4.3383
PMCID: PMC7571820

Genes

BRCA1
BRCA2
ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.PMID 32813918Read ↗

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted TherapySemantic proximity Read ↗

Genetic alterations and their therapeutic implications in epithelial ovarian cancer.Semantic proximity Read ↗

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.Semantic proximity Read ↗

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesSemantic proximity Read ↗

Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Semantic proximity Read ↗

Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.Semantic proximity Read ↗

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.Semantic proximity Read ↗

Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).Semantic proximity Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read ↗

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.Semantic proximity Read ↗

Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.Semantic proximity Read ↗

Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.